{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:13:31Z","timestamp":1771031611834,"version":"3.50.1"},"reference-count":30,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205768","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:17:32Z","timestamp":1714047452000},"source":"Crossref","is-referenced-by-count":1,"title":["Identification of protein methyltransferases 5 associated with ferroptosis and immune cell infiltration of head and neck squamous cell carcinoma"],"prefix":"10.18632","author":[{"given":"Xiaoyue","family":"Zhang","sequence":"first","affiliation":[{"name":"Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China"},{"name":"Cancer Research Institute and School of Basic Medical Science, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China"},{"name":"The Second Department of Breast Surgery, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China"},{"name":"Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Peng","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma.","volume":"6","author":"Grandis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathmechdis-031521-041424","article-title":"Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma.","volume":"1","author":"Westra","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer.","volume":"39","author":"Saba","year":"2021","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.ctrv.2022.102361","article-title":"Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers.","volume":"10","author":"Chan","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41368-020-0084-8","article-title":"Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma.","volume":"1","author":"Lam","year":"2020","journal-title":"Int J Oral Sci"},{"key":"6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.","volume":"2","author":"Bruno","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1139\/bcb-2023-0212","article-title":"Protein arginine methyltransferase 1, a major regulator of biological processes.","volume":"10","author":"Davie","year":"2024","journal-title":"Biochem Cell Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.7150\/ijbs.89498","article-title":"Protein arginine methylation in viral infection and antiviral immunity.","volume":"1","author":"Wang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"9","doi-asserted-by":"publisher","first-page":"115456","DOI":"10.1016\/j.biopha.2023.115456","article-title":"The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application.","volume":"16","author":"Zhou","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10","doi-asserted-by":"publisher","first-page":"105124","DOI":"10.1016\/j.jbc.2023.105124","article-title":"CARM1 arginine methyltransferase as a therapeutic target for cancer.","volume":"29","author":"Bedford","year":"2023","journal-title":"J Biol Chem"},{"key":"11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41419-023-06148-6","article-title":"PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer.","volume":"1","author":"Li","year":"2023","journal-title":"Cell Death Dis"},{"key":"12","doi-asserted-by":"publisher","first-page":"113385","DOI":"10.1016\/j.celrep.2023.113385","article-title":"Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis.","volume":"4","author":"Liu","year":"2023","journal-title":"Cell Rep"},{"key":"13","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/s41467-023-37542-5","article-title":"PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.","volume":"1","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"14","doi-asserted-by":"publisher","first-page":"e2303812","DOI":"10.1002\/advs.202303812","article-title":"PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.","volume":"1","author":"Yin","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/abbs\/gmz006","article-title":"PRMT2\u03b2 suppresses autophagy and glycolysis pathway in human breast cancer MCF-7 cell lines.","volume":"5","author":"Zhong","year":"2019","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"16","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.7150\/ijbs.71581","article-title":"PRMT5 acts as a tumor suppressor by inhibiting Wnt\/\u03b2-catenin signaling in murine gastric tumorigenesis.","volume":"1","author":"Liu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"e114558","DOI":"10.15252\/embj.2023114558","article-title":"MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.","volume":"4","author":"Ren","year":"2023","journal-title":"EMBO J"},{"key":"18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1158\/0008-5472.CAN-23-1899","article-title":"CircMMP2(6,7) Cooperates with \u03b2-Catenin and PRMT5 to Disrupt Bone Homeostasis and Promote Breast Cancer Bone Metastasis.","volume":"8","author":"Li","year":"2024","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.","volume":"1","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism.","volume":"2","author":"Duan","year":"2022","journal-title":"Mol Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer.","volume":"2","author":"Gan","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2021.03.009","article-title":"Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms.","volume":"50","author":"Chen","year":"2021","journal-title":"Cancer Lett"},{"key":"23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.","volume":"5","author":"Rischin","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer.","volume":"1","author":"Sun","year":"2019","journal-title":"J Hematol Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer.","volume":"2","author":"Wang","year":"2023","journal-title":"Mol Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.","volume":"3","author":"Robinson","year":"2020","journal-title":"Cancer Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","article-title":"YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","volume":"3","author":"He","year":"2020","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-022-01510-2","article-title":"m6A modification: recent advances, anticancer targeted drug discovery and beyond.","volume":"2","author":"Chen","year":"2022","journal-title":"Mol Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"e0238961","DOI":"10.1371\/journal.pone.0238961","article-title":"Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms.","volume":"1","author":"Schuppert","year":"2020","journal-title":"PLoS One"},{"key":"30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1574887112666170209161444","article-title":"Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics.","volume":"1","author":"Wu","year":"2017","journal-title":"Rev Recent Clin Trials"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:17:35Z","timestamp":1714047455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":30,"alternative-id":["205768"],"URL":"https:\/\/doi.org\/10.18632\/aging.205768","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}